设计一个基于网络的平台,以动态估计3级质瘤的个性化条件生存率
Zhihao Yang1, Regina Chizi Tunje2, Jiajie Xia1
1The Central Hospital of Shaoxing University, Shaoxing City, Zhejiang Province, China.
Discover oncology
|November 17, 2025
概括
这项研究为3级质瘤患者开发了基于条件生存 (CS) 的名谱,改善了长期生存预测. 该工具提供个性化的风险评估,以帮助治疗规划和幸存者护理.
科学领域:
- 神经瘤学神经瘤学
- 生物统计学 生物统计学
- 癌症流行病学癌症流行病学
背景情况:
- 3级质瘤是具有可变预后的侵袭性脑瘤.
- 目前的生存模型缺乏为长期规划提供动态风险评估.
- 需要在质瘤患者中改进个性化风险预测.
研究的目的:
- 为了描述3级质瘤的动态生存趋势.
- 为个性化风险预测开发和验证基于条件生存 (CS) 的名谱.
- 创建一个基于Web的工具,用于临床应用.
主要方法:
- 利用了SEER数据库 (2000-2021) 对7278名3级质瘤患者的数据.
- 进行了CS和年度危险率分析,以测量随时间变化的生存率.
- 使用考克斯模型,ROC和DCA开发和验证了一种CS-nomogram,包括年龄,组织学和治疗因素.
主要成果:
- 在5年后,10年生存概率从29%增加到67%.
- 随着时间的推移,每年的危险率显著下降.
- 该CS-nomogram显示强烈的歧视 (AUC>0.75) 和校准,有效地根据风险对患者进行分层.
结论:
- 一个经过验证的CS-nomogram和在线计算器为3级质瘤提供了个性化的预后评估.
- 这些工具为治疗规划和随访提供了宝贵的指导.
- 动态生存评估可以提高质瘤患者的生存护理.
更多相关视频
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
9.5K
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.9K
相关概念视频
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Kaplan-Meier Approach
541
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
541
